Inventor · disambiguated record
Jiandong Yuan
Also filed as: YUAN JIANDONG
14 granted patents·6 pending applications·16 citations·filing 2006–2023
86Inventor score
Files withBRIGHTGENE BIO MEDICAL TECH CO LTD15BRIGHTGENE BIO MEDICAL TECHNOL1BRIGHTGENE BIO MEDICAL TECHNOLOGY SUZHOU CO LTD1GENEQUANTUM HEALTHCARE SUZHOU CO LTD1WISCONSIN ALUMNI RES FOUND1
Top patents by PatentIndex Score
20 records- 0186US10869863B2Multi-arm polymeric targeting anti-cancer conjugateBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2017·Granted Dec 22, 2020·3 cites·17 claims
- 0285US10538541B2Phosphoramidate compound and preparation method and crystal thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Jan 21, 2020·6 cites·14 claims
- 0384US10072122B2Carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2015·Granted Sep 11, 2018·3 cites·8 claims
- 0481US10689413B2Composition enriched in single isomer of NUC-1031 and preparation method and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Jun 23, 2020·4 cites·10 claims
- 0566US12226832B2Powder core-shell structures and methods thereforWISCONSIN ALUMNI RES FOUND·Filed 2022·Granted Feb 18, 2025·0 cites·14 claims
- 0664US12215133B2GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and useBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2023·Granted Feb 4, 2025·0 cites·8 claims
- 0764US10913756B2Phosphoramidate compound and preparation method and crystal thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2019·Granted Feb 9, 2021·0 cites·19 claims
- 0856US2024181072A1Anti-HER2 Antibody-Immune Agonist Conjugate and Applications ThereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0951US9796728B2Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereofBRIGHTGENE BIO-MEDICAL TECH CO LTD·Filed 2015·Granted Oct 24, 2017·0 cites·8 claims
- 1050US10759905B2Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancerBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Sep 1, 2020·0 cites·9 claims
- 1149US2024209056A1Gip and glp-1 dual receptor agonist, pharmaceutical composition, and useBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1245US10292940B2Hyaluronic acid-based amphiphilic polymer, preparation method and application thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted May 21, 2019·0 cites·11 claims
- 1345US8507463B2Nucleotide analogue prodrug and the preparation thereofYUAN JIANDONG·Filed 2011·Granted Aug 13, 2013·0 cites·4 claims
- 1444US12122784B2Preparation method for ecteinascidin compound and intermediate thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2019·Granted Oct 22, 2024·0 cites·25 claims
- 1544US11191843B2Multi-arm targeting anti-cancer conjugateBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2018·Granted Dec 7, 2021·0 cites·18 claims
- 1643US2018360766A1Ovarian cancer specifically targeted biodegradable amphiphilic polymer, polymer vesicle prepared thereby and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2018·Application pending·0 cites
- 1739US2010216822A1Nucleotide Analogue Prodrug and the Preparation ThereofBRIGHTGENE BIO MEDICAL TECHNOL·Filed 2006·Application pending·0 cites
- 1836US2015322071A1Process for preparing triazole pyrimidine compounds and intermediates thereofBRIGHTGENE BIO MEDICAL TECHNOLOGY SUZHOU CO LTD·Filed 2013·Application pending·0 cites
- 1935US11179467B2Exenatide modifier and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Nov 23, 2021·0 cites·2 claims
- 2032US2018237466A1Preparation Method of Nucleoside Phosphoramidate Prodrugs and Intermediates ThereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiandong Yuan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →